A prescription for the drug industry

August 1993
U.S. News & World Report;8/9/93, Vol. 115 Issue 6, p20
Reports that President Bill Clinton's impending health care reforms, along with price pressures from insurers, have sent the pharmaceutical industry scurrying to cut costs. Recent purchase of drug distributer Medco Containment Services by drug firm Merck & Co.; How deal could prompt other alliances between drug makers and discount distributors.


Related Articles

  • MERCK LICENSES REMOVAL TECHNOLOGY TO SUPERIOR ADSORBENTS.  // Industrial Environment;Dec2002, Vol. 13 Issue 12, p6 

    Provides information on the agreement of Merck & Co. Inc. to license its patented mercury vapor removal technology to Superior Adsorbents Inc., a specialty sorbents manufacturer.

  • Deal in the making.  // Business News New Jersey;10/06/97, Vol. 10 Issue 34, p3 

    Reports that the Medco division of Merck Pharmaceutical company would be moving into the IBM campus in Franklin Lake which is owned by Gale and Wentworth. Information on the interest of other clients in the complex.

  • More testing = more drugs.  // HealthFacts;Aug96, Vol. 21 Issue 207, p1 

    Reports on Merck's financial agreement with two manufacturers of bone measurement equipment. Aim of increasing the availability of bone densitometers in doctors' offices; Merck's misleading advertisement for its osteoporosis drug called Fosamax.

  • Corporate council honors Merck for Costa Rica project.  // International Wildlife;May/Jun93, Vol. 23 Issue 3, p26 

    Announces award of the Environmental Achievement Award of the National Wildlife Federation's Corporate Conservation Council to Merck & Co., Inc. Merck's 1991 agreement to pay one million dollars to INBio (the Costa Rican National Institute of Biodiversity) for the exclusive right to collect and...

  • Bitter pill.  // Drug Topics;10/21/96, Vol. 140 Issue 20, p21 

    Reports that Merck and Co.'s Fosamax anti-osteoporosis pill causes esophageal damage to women.

  • Vioxx.  // Formulary;Jun2002, Vol. 37 Issue 6, p282 

    Features the drug Vioxx, a rofecoxib tablet and oral suspension from Merck & Co. Inc. Efficacy; Administration; Pricing.

  • Merck supports chemical prospecting in Costa Rica.  // BioScience;Feb1992, Vol. 42 Issue 2, p151 

    Announces that Merck & Co. Inc. and Costa Rica's Instituto Nacional de Biodiversidad (INBio) have formed a collaborative agreement that will give the company the right to new microorganisms, drugs, and other substances that might be discovered in a search of the country's nature reserves. Terms...

  • MERCK stops making monovalent vaccines. Andre, Laura // Mothering;Jan/Feb2010, Issue 158, p35 

    The article reports on the announcement from Merck & Co. Inc. regarding on the unavailability of its monovalent vaccines for measle, mumps, and rubella which has an adverse effects to children.

  • Now you see it, now you don't. Portansky, Elena // Drug Topics;8/3/98, Vol. 142 Issue 15, p16 

    Presents information on a triptan called Maxalt-MLT developed by Merck Co., which can be used in the treatment of acute migraine pain. Features of the drug; Comments from Stephen Siberstein, M.D., director of the Jefferson Headache Clinic, Philadelphia; Details on the approval of the drug by...

  • Helping two companies form a third.  // Personnel Journal;Jan94, Vol. 73 Issue 1, p63 

    Features pharmaceutical company Merck & Company, which won the Personnel Journal Optimas Awards for Service. Corporate background; Partnership of Merck with DuPont; Role of human resources in joint enterprises; Resolution of functions surrounding the merger of companies; Promotion of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics